6.190USD-1.90%Mkt Cap: 584.63M $P/E: —1d ago
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides …
Industry Peers
Diagnostics & Research$201.86BUSDP/E 29.8
$145.10BUSDP/E 39.7
$45.85BUSDP/E 44.2
$45.44BUSDP/E 42.4
$38.64BUSD
$38.44BUSDP/E 27.3
$37.13BUSDP/E 48.1
$35.13BUSDP/E 26.2
$28.78BUSDP/E 34.6
$26.98BUSDP/E 31.4
$23.18BUSDP/E 23.1
$23.12BUSDP/E 25.0
$20.55BUSD
$15.36BUSDP/E 33.9
$13.06BUSDP/E 27.3
$12.46BUSDP/E 53.7
$11.04BUSD
$9.26BUSDP/E 21.6
$5.90BUSDP/E 237.4
$5.68BUSD
$5.21BUSDP/E 44.6
$4.95BUSD
$4.73BUSDP/E 54.8
$3.75BUSDP/E 26.5
$3.54BUSD
$3.09BUSD
$2.08BUSD
$1.93BUSD
$1.83BUSD
$1.64BUSDP/E 41.7
$1.63BUSD
$1.48BUSDP/E 22.4
$1.02BUSDP/E 21.4
$898.56MUSD
$734.89MUSD
$616.40MUSDP/E 40.2
$583.63MUSD
$293.12MUSDP/E 2.9
$292.75MUSD
$206.70MUSD
$152.09MUSD
$139.43MUSD
$97.25MUSD
$102.68MUSD
$89.37MUSDP/E 17.2
$73.19MUSD
$58.55MUSD
$42.32MUSD
$30.71MUSD
$26.61MUSD
$20.94MUSD
$16.60MUSD
$12.04MUSD
$9.95MUSD
$8.70MUSD
$8.87MUSD
$7.73MUSD
$7.43MUSD
$6.69MUSD
$6.06MUSD
$5.06MUSD
$4.47MUSD
$4.44MUSD
$2.95MUSD
$3.29MUSD
$3.18MUSD
$869.0KUSD
$314.2KUSDP/E Infinity
$19.6KUSD
Indicators:|
| Headline | Source | Time |
|---|---|---|
This week | ||
 Is This the Right Time to Hold MYGN Stock in Your Portfolio? Myriad Genetics expands its testing portfolio and advances its Cancer Care Continuum strategy. Can reimbursement risks and cost pressures temper growth? | ||
Older | ||